Clinical Trials Directory

Trials / Unknown

UnknownNCT02601768

Occluder Size Determination in Transcatheter ASD II Closure Based on 3D TEE Assessment

Occluder Size Determination in Transcatheter Closure of Ostium Secundum Atrial Septal Defect Based on Three-Dimensional Echocardiography Assessment

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
National Institute of Cardiology, Warsaw, Poland · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to determine whether three-dimensional tranesophageal echocardiography (3D TEE) assessment of ostium secundum atrial septal defect (ASD II) may be as efficient as two-dimensional (2D) TEE assessment complemented by the balloon-sizing during transcatheter closure of the defect.

Detailed description

A total of 50 consecutive patients eligible to percutaneous ASD II closure will be enrolled in the study. 3D-TEE will be performed in the diagnostic process; the images will be recorded for further investigation, however, measurments of the defect will not be taken until after the procedure. Traditional 2D-TEE together with balloon-sizing assessment of the defect will be performed in enrolled patients in order to chose a device. Control transthoracic echocardiography (TTE) will be provided twice to evaluate the outcome of transcatheter treatment: 1 day after the procedure and 6-12 months later. The previously obtained 3D images will be retrospectively assessed by 2 independent investigators excluded from the interventionalists' team. Maximum and minimum diameter, perimeter and area of the defect will be measured to propose the assumed optimal occluder size. Correlation between proposed occluder size and the device used during the procedure will be statistically analyzed.

Conditions

Interventions

TypeNameDescription
DEVICETranscatheter closure of ASD IITranscatheter closure of ASD II performed in our center.

Timeline

Start date
2015-01-01
Primary completion
2016-06-01
Completion
2016-12-01
First posted
2015-11-10
Last updated
2015-11-10

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT02601768. Inclusion in this directory is not an endorsement.